Usefulness of total cholesterol/HDL‐cholesterol ratio in the management of diabetic dyslipidaemia
- 2 December 2004
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (1) , 26-31
- https://doi.org/10.1111/j.1464-5491.2004.01341.x
Abstract
Our aim was to evaluate the usefulness of the total cholesterol/HDL-cholesterol ratio (TC/HDL) in predicting the cardiovascular risk of Type 2 diabetic patients. Prospective cohort study with inclusion of 418 Type 2 diabetic individuals with follow-up until the appearance of a cardiovascular event. The predictive power of updated mean lipid values during follow-up was analysed by means of Cox proportional hazard models. An estimate was made of the relative risk (RR) conferred by high levels of TC/HDL stratified by LDL-cholesterol levels. Sixty-six cardiovascular events occurred during an average follow-up of 4.7 years (sd 1.5). The main lipid predictor of vascular events was mean TC/HDL ratio [hazard ratio (HR) = 1.46; 95% confidence interval (CI) 1.25, 1.7; P < 0.0001]. In the multivariate model with simultaneous inclusion of mean TC/HDL and mean LDL-cholesterol, both were significant predictors of cardiovascular disease [HR (1 unit) = 1.37; 95% CI 1.16, 1.62; P = 0.0003 and HR (1 mmol/l) = 1.5; 95% CI 1.04, 2.18; P = 0.03, respectively]. The LDL adjusted RR for cardiovascular events due to high TC/HDL ratio, with 4.5 cut-off point, was 2.5 (95% CI 1.4, 4.3; P = 0.0007). For the stratum of subjects with average LDL cholesterol < 3.5 mmol/l, RR was 1.2 (95% CI 0.5, 2.8; P = NS) and for the stratum of average LDL cholesterol > 3.5 mmol/l, RR was 4 (95% CI 1.8, 9; P = 0.00013), with heterogeneity among strata (P = 0.044). It could be useful to include the TC/HDL ratio in treatment guides for diabetic dyslipidaemia, given their high predictive value and strong interaction with LDL cholesterol.Keywords
This publication has 29 references indexed in Scilit:
- UKPDS 60Stroke, 2002
- Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant StudiesJournal of Clinical Endocrinology & Metabolism, 2002
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Diabetic Dyslipidemia: Causes and ConsequencesJournal of Clinical Endocrinology & Metabolism, 2001
- A desktop guide to Type 2 diabetes mellitusDiabetic Medicine, 1999
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literatureArchives of internal medicine (1960), 1997
- Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in DiabetesDiabetic Medicine, 1995
- Management of Dyslipidemia in NIDDMDiabetes Care, 1990